OP214
Sarcoma of the jaws is a rare, aggressive malignancy with a 5-year survival rate ranging between 27% and 84%. The purpose of the present study is to present our experience with a cohort of 11 patients treated in two departments of Oral and maxillofacial Surgery.
Gespeichert in:
| Autor*in: |
Lazaridou, Maria [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2013 |
|---|
| Umfang: |
2 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole - 2012transfer abstract, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:49 ; year:2013 ; day:1 ; month:05 ; pages:84-85 ; extent:2 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.oraloncology.2013.03.223 |
|---|
| Katalog-ID: |
ELV021624968 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV021624968 | ||
| 003 | DE-627 | ||
| 005 | 20230623161811.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.oraloncology.2013.03.223 |2 doi | |
| 028 | 5 | 2 | |a GBVA2013002000009.pica |
| 035 | |a (DE-627)ELV021624968 | ||
| 035 | |a (ELSEVIER)S1368-8375(13)00297-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 650 |q VZ |
| 084 | |a 85.03 |2 bkl | ||
| 084 | |a 31.80 |2 bkl | ||
| 084 | |a 54.80 |2 bkl | ||
| 084 | |a 50.03 |2 bkl | ||
| 100 | 1 | |a Lazaridou, Maria |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a OP214 |
| 264 | 1 | |c 2013 | |
| 300 | |a 2 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Sarcoma of the jaws is a rare, aggressive malignancy with a 5-year survival rate ranging between 27% and 84%. The purpose of the present study is to present our experience with a cohort of 11 patients treated in two departments of Oral and maxillofacial Surgery. | ||
| 700 | 1 | |a Ntomouchtsis, Aris |4 oth | |
| 700 | 1 | |a Tsekos, Antonis |4 oth | |
| 700 | 1 | |a Boukovinas, Ioannis |4 oth | |
| 700 | 1 | |a Vahtsevanos, Konstantinos |4 oth | |
| 700 | 1 | |a Mangoudi, Doxa |4 oth | |
| 700 | 1 | |a Antoniadis, Konstantinos |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |t Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole |d 2012transfer abstract |g Amsterdam [u.a.] |w (DE-627)ELV011194073 |
| 773 | 1 | 8 | |g volume:49 |g year:2013 |g day:1 |g month:05 |g pages:84-85 |g extent:2 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.oraloncology.2013.03.223 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OPC-MAT | ||
| 936 | b | k | |a 85.03 |j Methoden und Techniken der Betriebswirtschaft |q VZ |
| 936 | b | k | |a 31.80 |j Angewandte Mathematik |q VZ |
| 936 | b | k | |a 54.80 |j Angewandte Informatik |q VZ |
| 936 | b | k | |a 50.03 |j Methoden und Techniken der Ingenieurwissenschaften |q VZ |
| 951 | |a AR | ||
| 952 | |d 49 |j 2013 |b 1 |c 0501 |h 84-85 |g 2 |y 49.2013, S84-, (2 S.) | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
m l ml |
|---|---|
| matchkey_str |
lazaridoumariantomouchtsisaristsekosanto:2013----:p |
| hierarchy_sort_str |
2013 |
| bklnumber |
85.03 31.80 54.80 50.03 |
| publishDate |
2013 |
| allfields |
10.1016/j.oraloncology.2013.03.223 doi GBVA2013002000009.pica (DE-627)ELV021624968 (ELSEVIER)S1368-8375(13)00297-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 650 VZ 85.03 bkl 31.80 bkl 54.80 bkl 50.03 bkl Lazaridou, Maria verfasserin aut OP214 2013 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Sarcoma of the jaws is a rare, aggressive malignancy with a 5-year survival rate ranging between 27% and 84%. The purpose of the present study is to present our experience with a cohort of 11 patients treated in two departments of Oral and maxillofacial Surgery. Ntomouchtsis, Aris oth Tsekos, Antonis oth Boukovinas, Ioannis oth Vahtsevanos, Konstantinos oth Mangoudi, Doxa oth Antoniadis, Konstantinos oth Enthalten in Elsevier Science Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole 2012transfer abstract Amsterdam [u.a.] (DE-627)ELV011194073 volume:49 year:2013 day:1 month:05 pages:84-85 extent:2 https://doi.org/10.1016/j.oraloncology.2013.03.223 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 85.03 Methoden und Techniken der Betriebswirtschaft VZ 31.80 Angewandte Mathematik VZ 54.80 Angewandte Informatik VZ 50.03 Methoden und Techniken der Ingenieurwissenschaften VZ AR 49 2013 1 0501 84-85 2 49.2013, S84-, (2 S.) 045F 610 |
| spelling |
10.1016/j.oraloncology.2013.03.223 doi GBVA2013002000009.pica (DE-627)ELV021624968 (ELSEVIER)S1368-8375(13)00297-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 650 VZ 85.03 bkl 31.80 bkl 54.80 bkl 50.03 bkl Lazaridou, Maria verfasserin aut OP214 2013 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Sarcoma of the jaws is a rare, aggressive malignancy with a 5-year survival rate ranging between 27% and 84%. The purpose of the present study is to present our experience with a cohort of 11 patients treated in two departments of Oral and maxillofacial Surgery. Ntomouchtsis, Aris oth Tsekos, Antonis oth Boukovinas, Ioannis oth Vahtsevanos, Konstantinos oth Mangoudi, Doxa oth Antoniadis, Konstantinos oth Enthalten in Elsevier Science Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole 2012transfer abstract Amsterdam [u.a.] (DE-627)ELV011194073 volume:49 year:2013 day:1 month:05 pages:84-85 extent:2 https://doi.org/10.1016/j.oraloncology.2013.03.223 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 85.03 Methoden und Techniken der Betriebswirtschaft VZ 31.80 Angewandte Mathematik VZ 54.80 Angewandte Informatik VZ 50.03 Methoden und Techniken der Ingenieurwissenschaften VZ AR 49 2013 1 0501 84-85 2 49.2013, S84-, (2 S.) 045F 610 |
| allfields_unstemmed |
10.1016/j.oraloncology.2013.03.223 doi GBVA2013002000009.pica (DE-627)ELV021624968 (ELSEVIER)S1368-8375(13)00297-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 650 VZ 85.03 bkl 31.80 bkl 54.80 bkl 50.03 bkl Lazaridou, Maria verfasserin aut OP214 2013 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Sarcoma of the jaws is a rare, aggressive malignancy with a 5-year survival rate ranging between 27% and 84%. The purpose of the present study is to present our experience with a cohort of 11 patients treated in two departments of Oral and maxillofacial Surgery. Ntomouchtsis, Aris oth Tsekos, Antonis oth Boukovinas, Ioannis oth Vahtsevanos, Konstantinos oth Mangoudi, Doxa oth Antoniadis, Konstantinos oth Enthalten in Elsevier Science Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole 2012transfer abstract Amsterdam [u.a.] (DE-627)ELV011194073 volume:49 year:2013 day:1 month:05 pages:84-85 extent:2 https://doi.org/10.1016/j.oraloncology.2013.03.223 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 85.03 Methoden und Techniken der Betriebswirtschaft VZ 31.80 Angewandte Mathematik VZ 54.80 Angewandte Informatik VZ 50.03 Methoden und Techniken der Ingenieurwissenschaften VZ AR 49 2013 1 0501 84-85 2 49.2013, S84-, (2 S.) 045F 610 |
| allfieldsGer |
10.1016/j.oraloncology.2013.03.223 doi GBVA2013002000009.pica (DE-627)ELV021624968 (ELSEVIER)S1368-8375(13)00297-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 650 VZ 85.03 bkl 31.80 bkl 54.80 bkl 50.03 bkl Lazaridou, Maria verfasserin aut OP214 2013 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Sarcoma of the jaws is a rare, aggressive malignancy with a 5-year survival rate ranging between 27% and 84%. The purpose of the present study is to present our experience with a cohort of 11 patients treated in two departments of Oral and maxillofacial Surgery. Ntomouchtsis, Aris oth Tsekos, Antonis oth Boukovinas, Ioannis oth Vahtsevanos, Konstantinos oth Mangoudi, Doxa oth Antoniadis, Konstantinos oth Enthalten in Elsevier Science Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole 2012transfer abstract Amsterdam [u.a.] (DE-627)ELV011194073 volume:49 year:2013 day:1 month:05 pages:84-85 extent:2 https://doi.org/10.1016/j.oraloncology.2013.03.223 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 85.03 Methoden und Techniken der Betriebswirtschaft VZ 31.80 Angewandte Mathematik VZ 54.80 Angewandte Informatik VZ 50.03 Methoden und Techniken der Ingenieurwissenschaften VZ AR 49 2013 1 0501 84-85 2 49.2013, S84-, (2 S.) 045F 610 |
| allfieldsSound |
10.1016/j.oraloncology.2013.03.223 doi GBVA2013002000009.pica (DE-627)ELV021624968 (ELSEVIER)S1368-8375(13)00297-2 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 650 VZ 85.03 bkl 31.80 bkl 54.80 bkl 50.03 bkl Lazaridou, Maria verfasserin aut OP214 2013 2 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Sarcoma of the jaws is a rare, aggressive malignancy with a 5-year survival rate ranging between 27% and 84%. The purpose of the present study is to present our experience with a cohort of 11 patients treated in two departments of Oral and maxillofacial Surgery. Ntomouchtsis, Aris oth Tsekos, Antonis oth Boukovinas, Ioannis oth Vahtsevanos, Konstantinos oth Mangoudi, Doxa oth Antoniadis, Konstantinos oth Enthalten in Elsevier Science Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole 2012transfer abstract Amsterdam [u.a.] (DE-627)ELV011194073 volume:49 year:2013 day:1 month:05 pages:84-85 extent:2 https://doi.org/10.1016/j.oraloncology.2013.03.223 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT 85.03 Methoden und Techniken der Betriebswirtschaft VZ 31.80 Angewandte Mathematik VZ 54.80 Angewandte Informatik VZ 50.03 Methoden und Techniken der Ingenieurwissenschaften VZ AR 49 2013 1 0501 84-85 2 49.2013, S84-, (2 S.) 045F 610 |
| language |
English |
| source |
Enthalten in Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole Amsterdam [u.a.] volume:49 year:2013 day:1 month:05 pages:84-85 extent:2 |
| sourceStr |
Enthalten in Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole Amsterdam [u.a.] volume:49 year:2013 day:1 month:05 pages:84-85 extent:2 |
| format_phy_str_mv |
Article |
| bklname |
Methoden und Techniken der Betriebswirtschaft Angewandte Mathematik Angewandte Informatik Methoden und Techniken der Ingenieurwissenschaften |
| institution |
findex.gbv.de |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole |
| authorswithroles_txt_mv |
Lazaridou, Maria @@aut@@ Ntomouchtsis, Aris @@oth@@ Tsekos, Antonis @@oth@@ Boukovinas, Ioannis @@oth@@ Vahtsevanos, Konstantinos @@oth@@ Mangoudi, Doxa @@oth@@ Antoniadis, Konstantinos @@oth@@ |
| publishDateDaySort_date |
2013-01-01T00:00:00Z |
| hierarchy_top_id |
ELV011194073 |
| dewey-sort |
3610 |
| id |
ELV021624968 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV021624968</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623161811.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.oraloncology.2013.03.223</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013002000009.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV021624968</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1368-8375(13)00297-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">650</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">85.03</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">31.80</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">54.80</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">50.03</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lazaridou, Maria</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">OP214</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">2</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Sarcoma of the jaws is a rare, aggressive malignancy with a 5-year survival rate ranging between 27% and 84%. The purpose of the present study is to present our experience with a cohort of 11 patients treated in two departments of Oral and maxillofacial Surgery.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ntomouchtsis, Aris</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tsekos, Antonis</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Boukovinas, Ioannis</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vahtsevanos, Konstantinos</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mangoudi, Doxa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Antoniadis, Konstantinos</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole</subfield><subfield code="d">2012transfer abstract</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011194073</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:49</subfield><subfield code="g">year:2013</subfield><subfield code="g">day:1</subfield><subfield code="g">month:05</subfield><subfield code="g">pages:84-85</subfield><subfield code="g">extent:2</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.oraloncology.2013.03.223</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-MAT</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">85.03</subfield><subfield code="j">Methoden und Techniken der Betriebswirtschaft</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">31.80</subfield><subfield code="j">Angewandte Mathematik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">54.80</subfield><subfield code="j">Angewandte Informatik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">50.03</subfield><subfield code="j">Methoden und Techniken der Ingenieurwissenschaften</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">49</subfield><subfield code="j">2013</subfield><subfield code="b">1</subfield><subfield code="c">0501</subfield><subfield code="h">84-85</subfield><subfield code="g">2</subfield><subfield code="y">49.2013, S84-, (2 S.)</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Lazaridou, Maria |
| spellingShingle |
Lazaridou, Maria ddc 610 ddc 650 bkl 85.03 bkl 31.80 bkl 54.80 bkl 50.03 OP214 |
| authorStr |
Lazaridou, Maria |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV011194073 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 650 - Management & auxiliary services |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 610 VZ 650 VZ 85.03 bkl 31.80 bkl 54.80 bkl 50.03 bkl OP214 |
| topic |
ddc 610 ddc 650 bkl 85.03 bkl 31.80 bkl 54.80 bkl 50.03 |
| topic_unstemmed |
ddc 610 ddc 650 bkl 85.03 bkl 31.80 bkl 54.80 bkl 50.03 |
| topic_browse |
ddc 610 ddc 650 bkl 85.03 bkl 31.80 bkl 54.80 bkl 50.03 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
a n an a t at i b ib k v kv d m dm k a ka |
| hierarchy_parent_title |
Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole |
| hierarchy_parent_id |
ELV011194073 |
| dewey-tens |
610 - Medicine & health 650 - Management & public relations |
| hierarchy_top_title |
Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV011194073 |
| title |
OP214 |
| ctrlnum |
(DE-627)ELV021624968 (ELSEVIER)S1368-8375(13)00297-2 |
| title_full |
OP214 |
| author_sort |
Lazaridou, Maria |
| journal |
Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole |
| journalStr |
Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2013 |
| contenttype_str_mv |
zzz |
| container_start_page |
84 |
| author_browse |
Lazaridou, Maria |
| container_volume |
49 |
| physical |
2 |
| class |
610 610 DE-600 610 VZ 650 VZ 85.03 bkl 31.80 bkl 54.80 bkl 50.03 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Lazaridou, Maria |
| doi_str_mv |
10.1016/j.oraloncology.2013.03.223 |
| dewey-full |
610 650 |
| title_sort |
op214 |
| title_auth |
OP214 |
| abstract |
Sarcoma of the jaws is a rare, aggressive malignancy with a 5-year survival rate ranging between 27% and 84%. The purpose of the present study is to present our experience with a cohort of 11 patients treated in two departments of Oral and maxillofacial Surgery. |
| abstractGer |
Sarcoma of the jaws is a rare, aggressive malignancy with a 5-year survival rate ranging between 27% and 84%. The purpose of the present study is to present our experience with a cohort of 11 patients treated in two departments of Oral and maxillofacial Surgery. |
| abstract_unstemmed |
Sarcoma of the jaws is a rare, aggressive malignancy with a 5-year survival rate ranging between 27% and 84%. The purpose of the present study is to present our experience with a cohort of 11 patients treated in two departments of Oral and maxillofacial Surgery. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-MAT |
| title_short |
OP214 |
| url |
https://doi.org/10.1016/j.oraloncology.2013.03.223 |
| remote_bool |
true |
| author2 |
Ntomouchtsis, Aris Tsekos, Antonis Boukovinas, Ioannis Vahtsevanos, Konstantinos Mangoudi, Doxa Antoniadis, Konstantinos |
| author2Str |
Ntomouchtsis, Aris Tsekos, Antonis Boukovinas, Ioannis Vahtsevanos, Konstantinos Mangoudi, Doxa Antoniadis, Konstantinos |
| ppnlink |
ELV011194073 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth |
| doi_str |
10.1016/j.oraloncology.2013.03.223 |
| up_date |
2024-07-06T20:06:25.536Z |
| _version_ |
1803861502759796736 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV021624968</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623161811.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.oraloncology.2013.03.223</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013002000009.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV021624968</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1368-8375(13)00297-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">650</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">85.03</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">31.80</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">54.80</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">50.03</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lazaridou, Maria</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">OP214</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">2</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Sarcoma of the jaws is a rare, aggressive malignancy with a 5-year survival rate ranging between 27% and 84%. The purpose of the present study is to present our experience with a cohort of 11 patients treated in two departments of Oral and maxillofacial Surgery.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ntomouchtsis, Aris</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tsekos, Antonis</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Boukovinas, Ioannis</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vahtsevanos, Konstantinos</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mangoudi, Doxa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Antoniadis, Konstantinos</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="t">Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole</subfield><subfield code="d">2012transfer abstract</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV011194073</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:49</subfield><subfield code="g">year:2013</subfield><subfield code="g">day:1</subfield><subfield code="g">month:05</subfield><subfield code="g">pages:84-85</subfield><subfield code="g">extent:2</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.oraloncology.2013.03.223</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-MAT</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">85.03</subfield><subfield code="j">Methoden und Techniken der Betriebswirtschaft</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">31.80</subfield><subfield code="j">Angewandte Mathematik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">54.80</subfield><subfield code="j">Angewandte Informatik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">50.03</subfield><subfield code="j">Methoden und Techniken der Ingenieurwissenschaften</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">49</subfield><subfield code="j">2013</subfield><subfield code="b">1</subfield><subfield code="c">0501</subfield><subfield code="h">84-85</subfield><subfield code="g">2</subfield><subfield code="y">49.2013, S84-, (2 S.)</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.400728 |